MedPath

The randomized duble blind parallel-group comparison test of the effect for eye function of the Bilberry extract and Lutei

Not Applicable
Conditions
healthy subject
Registration Number
JPRN-UMIN000028736
Lead Sponsor
Omnica Co.,Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1, Subjects who have previous medical history of serious diseases (e.g., cancer, cardiac arrest, cardiac infarct). 2, Subjects who have previous medical history and/or current medical history of serious diseases(e.g., arrhythmia, liver disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, other chronic diseases) 3, Subjects who have undergone gastrointestinal tract surgery; except appendectomy. 4, Subjects who take medicines. 5, Subjects who have an eye disease. 6, Subjects who are allergic to medicines or the test material of this trial. 7, Subjects who are or are possibly pregnant, or are lactating. 8, Subjects who participate in other clinical trials in the past 3 months. 9, Subjects who work time is irregular. 10, Smoker 11, Subjects who have been determined ineligible by principal investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ear-reflex: intake 0,12 weeks
Secondary Outcome Measures
NameTimeMethod
Contrast sensitivity: intake 0, 12 weeks MPOD: intake 0, 12 weeks Blood lutein concentration: intake 0, 12 weeks Subjective symptoms: intake 0,12 weeks Safety(blood test, urinary test, history taking):intake 0, 12 weeks
© Copyright 2025. All Rights Reserved by MedPath